Skip to main content

Table 1 The clinicopathological characteristics of 170 patients with gastric cancer

From: The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression

  Number (N) Percentage (%)
Gender   
Male 97 57.06
Female 73 42.94
Age   
≤50 years 34 20.00
>50 years 136 80.00
Tumor Location   
Proximal 79 46.47
Distal 91 53.53
Tumor Size (cm)   
≤5 115 67.65
>5 55 32.35
Lauren Classification   
Intestinal 73 42.94
Diffuse 97 57.06
Tumor Stage   
Early 90 52.94
Advanced 80 47.06
LN Metastasis   
No 74 43.53
Yes 96 56.47
Endpoint Status   
Survival 95 55.88
Death 75 44.12
OPN Staining   
≤50% 79 46.47
>50% 91 53.53
CD204 Staining   
≤50% 79 46.47
>50% 91 53.53